FB
Fortress Biotech, Inc.
FBIO · NASDAQ
$2.46 -0.81% (-$0.02)
1M -15.46%
Market Cap $81.7M
P/E Ratio 0.73x
Div. Yield -
ROE 103.52%
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/FCF 0.65x
P/B 0.50x
P/E 0.73x
Growth
13 /100
Declining Book val. growth 6.13%
Rev. growth 5.83%
FCF growth N/A
Profitability
70 /100
Strong FCF margin 183.80%
Op. margin 42.86%
Gross margin 62.53%
Quality
48 /100
Average Asset turnover 0.22x
ROA 35.31%
ROIC 10.85%
Debt
98 /100
Low Net debt/EBITDA -0.82x
Int. coverage 17.26x
Debt/Equity 0.39x
Stability
53 /100
Moderate Profitable years 1
EPS volatility 27.87%
Beta 1.19x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na FBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lindsay A. Rosenwald
Employees
78
Headquarters
Bay Harbor Islands
Nadcházející události
16 LIS
Earnings
Upcoming earnings report